Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 89

Sort by

Sort Order Select

Journal Articles

Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma

Blood (2019) 134 (Supplement_1): 4571.

https://doi.org/10.1182/blood-2019-123088

Published: 2019

Journal Articles

Outpatient BEAM Using Daily Etoposide and Cytarabine with Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Is Feasible and Decreases Inpatient Length of Stay

Blood (2019) 134 (Supplement_1): 5830.

https://doi.org/10.1182/blood-2019-127402

Published: 2019

Journal Articles

Impact of HLA Class I Allele Mismatch on Viral Infection within 100 Days after Cord Blood Transplantation

Tomoki Iemura, MD, Yasuyuki Arai, MD PhD, Junya Kanda, MD, Toshio Kitawaki, MD PhD, Masakatsu Hishizawa, MD PhD, Tadakazu Kondo, MD PhD, Kouhei Yamashita, MD PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2019) 134 (Supplement_1): 3267.

https://doi.org/10.1182/blood-2019-123073

Published: 2019

Journal Articles

Key Histopathology Features of Cutaneous Acute Graft-Versus-Host Disease Can be Detected Noninvasively

Inga Saknite, PhD, Melissa Gill, MD, Alessi-Fox Christi, MS, Jeffrey P Zwerner, MD PhD, Julia S Lehman, MD, Michi M Shinohara, MD, Roberto A Novoa, MD, Michael T Byrne, DO, Madan Jagasia, MBBS, MS, MMHC, Salvador Gonzalez, MD PhD, Marco Ardigo, MD PhD, Eric R. Tkaczyk, MD PhD

Blood (2019) 134 (Supplement_1): 3278.

https://doi.org/10.1182/blood-2019-131317

Published: 2019

Journal Articles

Engraftment Syndrome in the Setting of Autologous Stem Cell Transplantation for Multiple Myeloma-a Single Institution Review of over 600 Patients

Sudarsan Kollimuttathuliam, MD, Phyllis McKiernan, David S. Siegel, Scott D. Rowley, MD, Noa Biran, MD, David H. Vesole, MD PhD, Themba Nyirenda, PhD, Andrew L. Pecora, MD, Stuart L. Goldberg, MD, Andre Goy, MD, Michele L. Donato, MD

Blood (2019) 134 (Supplement_1): 4576.

https://doi.org/10.1182/blood-2019-132052

Published: 2019

Journal Articles

Predictive Values of Early ST2 for Acute Graft-Versus-Host Disease and Transplant-Related Complications after Allogeneic Stem Cell Transplantation

Takuya Miyazaki, Ayako Matsumura, MD, Takayoshi Tachibana, Taiki Ando, MD, Megumi Koyama, MD, Satoshi Koyama, MD, Yoshimi Ishii, MD, Hiroyuki Takahashi, MD, Yuki Nakajima, MD, Ayumi Numata, MD, Wataru Yamamoto, MD, Kenji Motohashi, MD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD, Shin Fujisawa, MD, Hideaki Nakajima, MD

Blood (2019) 134 (Supplement_1): 1976.

https://doi.org/10.1182/blood-2019-123262

Published: 2019

Journal Articles

Post-Transplant Cyclophosphamide in Allogeneic Bone Marrow Transplantation for the Treatment of Benign Hematologic Diseases

Mark Leick, MD, Bradley Hunter, MD MPH, Zachariah Defilipp, MD, Bimalangshu Dey, MD, Areej El-Jawahri, MD, Matthew J. Frigault, MD, Steven L McAfee, MD, Thomas Spitzer, MD, Paul V. O'Donnell, MD PhD, Yi-Bin Chen

Blood (2019) 134 (Supplement_1): 1978.

https://doi.org/10.1182/blood-2019-128295

Published: 2019

Journal Articles

The Impact of HLA Mismatch Direction on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in AML Patients

Wen-Chun Chen, MD, Jyh-Pyng Gau, Sr., MD, Liang-Tsai Hsiao, MD PhD, Chia-Jen Liu, MD, Yao-Chung LIU, MD, Hao-Yuan Wang, MD, Po-Shen Ko, MD, Jin-Hwang Liu, MD PhD, Tzeon-Jye Chiou, MD

Blood (2019) 134 (Supplement_1): 4608.

https://doi.org/10.1182/blood-2019-125179

Published: 2019

Journal Articles

Donor Cell Acute Myeloid Leukemia after Transplant for Follicular Lymphoma

Lacey S. Williams, MD, Catherine E. Lai, MD

Blood (2019) 134 (Supplement_1): 5697.

https://doi.org/10.1182/blood-2019-122932

Published: 2019

Journal Articles

Evomela® Significantly Increases the Risk of Engraftment Syndrome in Patients with Multiple Myeloma Treated with Autologous Stem Cell Transplantation

Marshall McKenna, MD, Phyllis McKiernan, David S. Siegel, Scott D. Rowley, MD, Noa Biran, MD, David H. Vesole, MD PhD, Stuart L. Goldberg, MD, Themba Nyirenda, PhD, Andrew L. Pecora, MD, Andre Goy, MD, Michele L. Donato, MD

Blood (2019) 134 (Supplement_1): 3316.

https://doi.org/10.1182/blood-2019-132114

Published: 2019

Journal Articles

Outcome of Ruxolitinib and Sirolimus in Preventing aGVHD Post to HLA Matched Hemotopietic Stem Cell Transplantation

Sanbin Wang, Xiaoli Huang, Lin Liu, Yang Liang

Blood (2018) 132 (Supplement 1): 5727.

https://doi.org/10.1182/blood-2018-99-119109

Published: 2018

Journal Articles

Evaluation of T Cell and Monocyte Immune Subsets in the Stem Cell Product of Patients Developing Engraftment Syndrome Following Autologous Stem Cell Transplantation for Multiple Myeloma and Lymphoma

Dante B. Descalzi-Montoya, PhD, Zheng Yang, MS, Kira Goldgirsh, MS, Rena Feinman, PhD, David S Siegel, MD PhD, Noa Biran, MD, David H. Vesole, MD PhD, Andre Goy, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Scott D. Rowley, MD, Alan P Skarbnik, MD, Phyllis McKiernan, Melissa Baker, MSN, ANP, Michele L. Donato, MD, Robert Korngold, PhD

Blood (2018) 132 (Supplement 1): 4604.

https://doi.org/10.1182/blood-2018-99-120103

Published: 2018

Journal Articles

Long-Term Durable Responses after Autologous Stem Cell Transplantation in POEMS Syndrome

Blood (2018) 132 (Supplement 1): 4606.

https://doi.org/10.1182/blood-2018-99-115710

Published: 2018

Journal Articles

Homebound Autologous Hematopoietic Cell Transplantation for Plasma Cell Disorders in an Urban Setting Is Safe for Patients and Preferred By Patients and Caregivers

Blood (2018) 132 (Supplement 1): 2258.

https://doi.org/10.1182/blood-2018-99-120049

Published: 2018

Journal Articles

Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treatment of Multiple Myeloma and Lymphoma

Stacey L. Fanning, PhD, Kira Goldgirsh, MS, Dante B. Descalzi-Montoya, PhD, Rena Feinman, PhD, David S Siegel, MD PhD, Noa Biran, MD, David H. Vesole, MD PhD, Andre Goy, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Scott D. Rowley, MD, Alan P Skarbnik, MD, Phyllis McKiernan, Melissa Baker, MSN, ANP, Michele L. Donato, MD, Robert Korngold, PhD

Blood (2018) 132 (Supplement 1): 2131.

https://doi.org/10.1182/blood-2018-99-118763

Published: 2018

Journal Articles

Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Noa Biran, MD, Shijia Zhang, MD PhD, Scott D. Rowley, MD, David H. Vesole, MD PhD, Michele L. Donato, MD, Alan P Skarbnik, MD, Joshua R Richter, MD, Andrew L. Pecora, MD, David S Siegel, MD PhD

Blood (2018) 132 (Supplement 1): 2154.

https://doi.org/10.1182/blood-2018-99-114832

Published: 2018

Journal Articles

Cyclophosphamide Based Regimens Compared to Plerixafor-Based Regimens for Stem Cell Mobilization in Patients with Multiple Myeloma Result in Higher CD34+ Cell Yield, Lower Cost and Similar Outcome Post Autologous Transplantation

Rima M Panchal, MD, Phyllis McKiernan, APN, MSN, David Siegel, MD PhD, Scott D. Rowley, MD, David H. Vesole, MD PhD, Tracy Andrews, PhD, Andrea Ortega, RN, Alan P Skarbnik, MD, Noa Biran, MD, Joshua R Richter, MD, Nino Aleksidze, MD, Andrew L. Pecora, MD, Andre Goy, MD, Maribel Pereiras, Pharm D, Michele L. Donato, MD

Blood (2017) 130 (Supplement 1): 3283.

https://doi.org/10.1182/blood.V130.Suppl_1.3283.3283

Published: 2017

Journal Articles

Risk of Engraftment Syndrome after Autologous Stem Cell Transplantation for Multiple Myeloma Increases with Age and Lower Dose of CD34+ Cells, but Is Not Impacted By Immunomodulatory Chemotherapy

Phyllis McKiernan, APN, MSN, David Siegel, MD PhD, Scott D. Rowley, MD, David H. Vesole, MD PhD, Tracy Andrews, PhD, Andrea Ortega, RN, Alan P Skarbnik, MD, Noa Biran, MD, Joshua R Richter, MD, Andrew L. Pecora, MD, Andre Goy, MD, Rima M Panchal, MD, Nino Aleksidze, MD, Michele L. Donato, MD

Blood (2017) 130 (Supplement 1): 3284.

https://doi.org/10.1182/blood.V130.Suppl_1.3284.3284

Published: 2017

Journal Articles

Treatment Evolution for Multiple Myeloma before Autologous Stem Cell Transplant and Its Relation with Engraftment Syndrome: 15 Years of Experience

Adolfo E Diaz, MD, Juan J. Toro, MD MSci, Shuko Lee, MS, Vivian Dee, NP, Francisca Cecilia Gushiken, MD

Blood (2017) 130 (Supplement 1): 3241.

https://doi.org/10.1182/blood.V130.Suppl_1.3241.3241

Published: 2017

Journal Articles

Cord Blood Regulatory T Cells for Prevention of Graft Versus Host Disease

Joshua Kellner, Stefan O. Ciurea, Amanda L. Olson, MD, Yago Nieto, MD PhD, Borje S Andersson, MDPhD, Joseph David Khoury, MD, Richard E. Champlin, MD, Stefan Nierkens, PhD, Jaap Jan Boelens, MD PhD, Bruce Blazar, MD, Simrit Parmar, MBBS

Blood (2017) 130 (Supplement 1): 3246.

https://doi.org/10.1182/blood.V130.Suppl_1.3246.3246

Published: 2017

NARROW

Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma

Outpatient BEAM Using Daily Etoposide and Cytarabine with Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Is Feasible and Decreases Inpatient Length of Stay

Impact of HLA Class I Allele Mismatch on Viral Infection within 100 Days after Cord Blood Transplantation

Key Histopathology Features of Cutaneous Acute Graft-Versus-Host Disease Can be Detected Noninvasively

Engraftment Syndrome in the Setting of Autologous Stem Cell Transplantation for Multiple Myeloma-a Single Institution Review of over 600 Patients

Predictive Values of Early ST2 for Acute Graft-Versus-Host Disease and Transplant-Related Complications after Allogeneic Stem Cell Transplantation

Post-Transplant Cyclophosphamide in Allogeneic Bone Marrow Transplantation for the Treatment of Benign Hematologic Diseases

The Impact of HLA Mismatch Direction on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in AML Patients

Donor Cell Acute Myeloid Leukemia after Transplant for Follicular Lymphoma

Evomela® Significantly Increases the Risk of Engraftment Syndrome in Patients with Multiple Myeloma Treated with Autologous Stem Cell Transplantation

Outcome of Ruxolitinib and Sirolimus in Preventing aGVHD Post to HLA Matched Hemotopietic Stem Cell Transplantation

Evaluation of T Cell and Monocyte Immune Subsets in the Stem Cell Product of Patients Developing Engraftment Syndrome Following Autologous Stem Cell Transplantation for Multiple Myeloma and Lymphoma

Long-Term Durable Responses after Autologous Stem Cell Transplantation in POEMS Syndrome

Homebound Autologous Hematopoietic Cell Transplantation for Plasma Cell Disorders in an Urban Setting Is Safe for Patients and Preferred By Patients and Caregivers

Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treatment of Multiple Myeloma and Lymphoma

Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Cyclophosphamide Based Regimens Compared to Plerixafor-Based Regimens for Stem Cell Mobilization in Patients with Multiple Myeloma Result in Higher CD34+ Cell Yield, Lower Cost and Similar Outcome Post Autologous Transplantation

Risk of Engraftment Syndrome after Autologous Stem Cell Transplantation for Multiple Myeloma Increases with Age and Lower Dose of CD34+ Cells, but Is Not Impacted By Immunomodulatory Chemotherapy

Treatment Evolution for Multiple Myeloma before Autologous Stem Cell Transplant and Its Relation with Engraftment Syndrome: 15 Years of Experience

Cord Blood Regulatory T Cells for Prevention of Graft Versus Host Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only